All Posts: brain research
22 Articles
- GUMC Stories
Georgetown’s José Merino Becomes Editor-In-Chief of the World’s Leading Clinical Neurology Journal
(April 18, 2020) — José G. Merino, MD, MPhil, FAHA, FAAN, professor of neurology at Georgetown University School of Medicine, became interested in medical journals as a medical…
April 18, 2020
- News Release
Veterans Study Suggests Two Subtypes of Gulf War Illness
Brain imaging of veterans with Gulf War illness show varying abnormalities after moderate exercise that can be categorized into two distinct groups — an outcome that suggests a…
December 12, 2019
- News Release
Why Adults at Risk for Huntington’s Disease Choose Not to Learn if They Inherited Deadly Gene
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (May 16, 2019) — As many as 90 percent of individuals who have a parent with Huntington’s disease (HD) choose not to take…
May 16, 2019
- GUMC Stories
Impacted by Parkinson’s Disease, Three Couples Plan to Leave a Lasting Legacy to Support Research
(April 26, 2019) — When someone is diagnosed with an incurable, life-changing disease like Parkinson’s, they usually have many questions about how it will affect their life and…
April 26, 2019
- News Release
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in…
March 12, 2019
- GUMC Stories
Doctors Speak Out Panelists on the Progress and Promise of Huntington’s Disease Research
A recent Doctors Speak Out event highlighted the progress scientists have made toward understanding Huntington’s disease, the promise of recent research developments, and…
October 1, 2018
- News Release
Use of Electrical Brain Stimulation to Foster Creativity Has Sweeping Implications
What is creativity, and can it be enhanced — safely — in a person who needs a boost of imagination? In a newly published article, Georgetown experts debate the…
September 18, 2018
- News Release
Georgetown Clinical Trial Testing Nilotinib in Alzheimer’s Disease Begins
A clinical trial to examine the effect of nilotinib on clinical outcomes and biomarkers in people with mild to moderate Alzheimer’s disease has opened at Georgetown…
January 18, 2017
- News Release
Resveratrol Impacts Alzheimer’s Disease Biomarker
WASHINGTON — The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer’s disease found that a…
September 5, 2015
- GUMC Stories
Patients Drive Support Of Parkinson’s Fellowship Program
March 2, 2015 — Twelve years ago, Rick Schena, a United Airlines pilot, felt something amiss in the body he has always been so in tune with — the onset of tremors, some rigidity,…
March 2, 2015